Xolair FDA finds heart and brain problems

Discussion in 'Novartis' started by Anonymous, Sep 30, 2014 at 8:31 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Another Novartis drug showing signs of severe side effects. Good luck with the new CV drug I hope Novartis does not flush this one down the toilet like so many others. It just seems that every drug ends up with some kind of problem, even Diovan now faces lawsuits in Japan for fixing the data. Here is a company that had such a strong pipeline but never could get them through the FDA why? Will they learn from past mistakes ?
     

  2. Anonymous

    Anonymous Guest

    Galvus , spent millions on pre promotions priming the pump for DPP4, Merck laughs all the way to the bank with Januvia. The brains didn't want to go for BID & monkey testicle rashes

    Zelnorm , promoted off label as a prep, reps promoted into management until strokes & heart attacks kill off a few patients=drug RIP while Linzess is doing fine in the IBS market

    Valturna -& rat data , pulled

    Lucentis -price fixing in Europe

    Diovan - bogus studies & data

    Gleevec / Tasigna - 10K side effects shredded , 4k of them severe

    Lescol - crappiest statin

    Fanapt - ?? lol !!

    Reclast/Zometa - osteonecrosis of the jaw

    Lamisil - Black Box

    Gilenya- first dose monitoring

    You can go on forever.....
     
  3. Anonymous

    Anonymous Guest

    What will Lisa and June do now to climb that corporate ladder?